103 related articles for article (PubMed ID: 26945136)
1. Androgen and breast cancer: an update.
McNamara KM; Sasano H
Curr Opin Endocrinol Diabetes Obes; 2016 Jun; 23(3):249-56. PubMed ID: 26945136
[TBL] [Abstract][Full Text] [Related]
2. Cholesterol synthesis inhibitor RO 48-8071 suppresses transcriptional activity of human estrogen and androgen receptor.
Mafuvadze B; Liang Y; Hyder SM
Oncol Rep; 2014 Oct; 32(4):1727-33. PubMed ID: 25051231
[TBL] [Abstract][Full Text] [Related]
3. Complexities of androgen receptor signalling in breast cancer.
McNamara KM; Moore NL; Hickey TE; Sasano H; Tilley WD
Endocr Relat Cancer; 2014 Aug; 21(4):T161-81. PubMed ID: 24951107
[TBL] [Abstract][Full Text] [Related]
4. Estrogen receptor beta--an independent prognostic marker in estrogen receptor alpha and progesterone receptor-positive breast cancer?
Maehle BO; Collett K; Tretli S; Akslen LA; Grotmol T
APMIS; 2009 Sep; 117(9):644-50. PubMed ID: 19703124
[TBL] [Abstract][Full Text] [Related]
5. Steroid hormone receptors as targets for the therapy of breast and prostate cancer--recent advances, mechanisms of resistance, and new approaches.
Hoffmann J; Sommer A
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):191-200. PubMed ID: 15860262
[TBL] [Abstract][Full Text] [Related]
6. Triple-negative breast cancer: role of the androgen receptor.
Gucalp A; Traina TA
Cancer J; 2010; 16(1):62-5. PubMed ID: 20164692
[TBL] [Abstract][Full Text] [Related]
7. Overcoming aromatase inhibitor resistance in breast cancer: possible mechanisms and clinical applications.
Hanamura T; Hayashi SI
Breast Cancer; 2018 Jul; 25(4):379-391. PubMed ID: 28389808
[TBL] [Abstract][Full Text] [Related]
8. Androgen receptor in estrogen receptor positive breast cancer: Beyond expression.
Basile D; Cinausero M; Iacono D; Pelizzari G; Bonotto M; Vitale MG; Gerratana L; Puglisi F
Cancer Treat Rev; 2017 Dec; 61():15-22. PubMed ID: 29078133
[TBL] [Abstract][Full Text] [Related]
9. The role of the androgen receptor in triple-negative breast cancer.
Shah PD; Gucalp A; Traina TA
Womens Health (Lond); 2013 Jul; 9(4):351-60. PubMed ID: 23826776
[TBL] [Abstract][Full Text] [Related]
10. Bringing androgens up a NOTCH in breast cancer.
Tarulli GA; Butler LM; Tilley WD; Hickey TE
Endocr Relat Cancer; 2014 Aug; 21(4):T183-202. PubMed ID: 25001242
[TBL] [Abstract][Full Text] [Related]
11. Minireview: The androgen receptor in breast tissues: growth inhibitor, tumor suppressor, oncogene?
Hickey TE; Robinson JL; Carroll JS; Tilley WD
Mol Endocrinol; 2012 Aug; 26(8):1252-67. PubMed ID: 22745190
[TBL] [Abstract][Full Text] [Related]
12. Modulating the Activity of Androgen Receptor for Treating Breast Cancer.
You CP; Tsoi H; Man EPS; Leung MH; Khoo US
Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499670
[TBL] [Abstract][Full Text] [Related]
13. Selective Androgen Receptor Modulator RAD140 Inhibits the Growth of Androgen/Estrogen Receptor-Positive Breast Cancer Models with a Distinct Mechanism of Action.
Yu Z; He S; Wang D; Patel HK; Miller CP; Brown JL; Hattersley G; Saeh JC
Clin Cancer Res; 2017 Dec; 23(24):7608-7620. PubMed ID: 28974548
[No Abstract] [Full Text] [Related]
14. Estrogen receptor alpha negative breast cancer patients: estrogen receptor beta as a therapeutic target.
Skliris GP; Leygue E; Watson PH; Murphy LC
J Steroid Biochem Mol Biol; 2008 Mar; 109(1-2):1-10. PubMed ID: 18243688
[TBL] [Abstract][Full Text] [Related]
15. Androgen metabolite-dependent growth of hormone receptor-positive breast cancer as a possible aromatase inhibitor-resistance mechanism.
Hanamura T; Niwa T; Nishikawa S; Konno H; Gohno T; Tazawa C; Kobayashi Y; Kurosumi M; Takei H; Yamaguchi Y; Ito K; Hayashi S
Breast Cancer Res Treat; 2013 Jun; 139(3):731-40. PubMed ID: 23780684
[TBL] [Abstract][Full Text] [Related]
16. The Estrogen Receptor Cofactor SPEN Functions as a Tumor Suppressor and Candidate Biomarker of Drug Responsiveness in Hormone-Dependent Breast Cancers.
Légaré S; Cavallone L; Mamo A; Chabot C; Sirois I; Magliocco A; Klimowicz A; Tonin PN; Buchanan M; Keilty D; Hassan S; Laperrière D; Mader S; Aleynikova O; Basik M
Cancer Res; 2015 Oct; 75(20):4351-63. PubMed ID: 26297734
[TBL] [Abstract][Full Text] [Related]
17. Estrogen receptor beta expression is associated with tamoxifen response in ERalpha-negative breast carcinoma.
Gruvberger-Saal SK; Bendahl PO; Saal LH; Laakso M; Hegardt C; Edén P; Peterson C; Malmström P; Isola J; Borg A; Fernö M
Clin Cancer Res; 2007 Apr; 13(7):1987-94. PubMed ID: 17404078
[TBL] [Abstract][Full Text] [Related]
18. Estrogen receptor alpha (ER alpha) mRNA copy numbers in immunohistochemically ER alpha-positive-, and negative breast cancer tissues.
Poola I; Yue Q
BMC Cancer; 2007 Mar; 7():56. PubMed ID: 17391528
[TBL] [Abstract][Full Text] [Related]
19. Oestrogen receptor negativity in breast cancer: a cause or consequence?
Gajulapalli VNR; Malisetty VL; Chitta SK; Manavathi B
Biosci Rep; 2016 Dec; 36(6):. PubMed ID: 27884978
[TBL] [Abstract][Full Text] [Related]
20. Reversal of the estrogen receptor negative phenotype in breast cancer and restoration of antiestrogen response.
Bayliss J; Hilger A; Vishnu P; Diehl K; El-Ashry D
Clin Cancer Res; 2007 Dec; 13(23):7029-36. PubMed ID: 18056179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
